Glioma Diagnosis And Treatment
20 researchers across 3 institutions
Research in glioma diagnosis and treatment focuses on understanding the molecular and cellular underpinnings of these aggressive brain tumors to develop more effective diagnostic and therapeutic strategies. Investigations explore novel imaging techniques for early and accurate detection, analyze genetic and epigenetic alterations to identify therapeutic targets, and evaluate new drug delivery systems and immunotherapies. Studies also examine the tumor microenvironment and its role in disease progression and treatment resistance. The ultimate aim is to improve patient outcomes through personalized medicine approaches.
This work holds significant relevance for Arkansas by addressing a critical public health challenge. Gliomas disproportionately affect various demographic groups, and advancing diagnostic and treatment capabilities can lead to better patient care within the state. Furthermore, research in this area can foster collaborations with the state's growing biotechnology and healthcare sectors, potentially leading to new diagnostic tools and therapeutic agents developed or tested within Arkansas. Understanding the specific genetic profiles of gliomas in the regional population may also inform targeted public health initiatives.
This research area draws on expertise from cancer genomics, pharmacology, neuroscience, medical imaging, and immunology. Engagement spans multiple institutions across Arkansas, fostering a collaborative environment to tackle the complex challenges of glioma.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| W. Sue T. Griffin | UAMS | 65 | 17,454 | Grant PI High Impact | |
| David K. Wilson | UAMS | 35 | 3,718 | High Impact | |
| Murat Gökden | UAMS | 27 | 2,908 | Grant PI High Impact | |
| Analiz Rodriguez | University of Arkansas | 26 | 7,562 | Grant PI High Impact | |
| Kevin Bielamowicz | UAMS | 20 | 3,311 | High Impact | |
| Leena Maddukuri | UAMS | 18 | 662 | ||
| Azemat Jamshidi‐Parsian | UAMS | 17 | 1,492 | Grant PI | |
| Megan R. Reed | UAMS | 15 | 663 | ||
| James S. Cordova | UAMS | 12 | 517 | ||
| Orwa Aboud | UAMS | 12 | 549 | ||
| J. Stephen Nix | UAMS | 9 | 382 | ||
| William J. Shelton | UAMS | 6 | 83 | ||
| Frederick F. Lang | UAMS | 6 | 1,057 | Grant PI | |
| Narasimhappagari Jagadeesh | UAMS | 6 | 100 | ||
| Omar Darwish | UAMS | 5 | 128 | ||
| April C.L. Bostian | UAMS | 4 | 77 | ||
| Luis Nunez | UAMS | 3 | 53 | ||
| Halyna Pokhylevych | UA Little Rock | 2 | 24 | ||
| Sogand Sadeghi | UAMS | 2 | 13 | ||
| William Jeremy Shelton-Correa | UAMS | 0 | 0 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Glioma Diagnosis And Treatment in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Neurological Surgery 6,378
- 2 The University of Texas MD Anderson Cancer Center 4,070
- 3 University of California, San Francisco 4,016
- 4 Harvard University 3,826
- 5 Massachusetts General Hospital 2,961
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Glioma Diagnosis And Treatment.